CURAPOD Bags ₹20 Cr To Scale Manufacturing Of Pain Management Device
Pain management device maker CURAPOD has secured ₹20 Cr ($2.2 Mn) in its pre-Series A funding round led by V3 Ventures, 3i Partners and Ideaspring Capital.
The healthtech startup said it plans to use the funds to accelerate its product and app enhancements, expand sales via launching in marketplaces, boost marketing efforts, deepen partnership with gyms, physiotherapy and sports medicine networks, and scale its manufacturing and go-to-market operations.
It will also use a part of the funds for international expansion. The startup said it is currently making preparations to enter the Europe market.
Founded in 2022 by Sri Velliyur and Surya Prakash Maguluri, CURAPOD manufactures a wearable medical device for musculoskeletal pain management.
The startup claims that the device, which is completely engineered and manufactured in India, is built on medical-grade photobiomodulation technology, including red light wavelengths. It works at a cellular level to help reduce inflammation, improve circulation, and support tissue repair, enabling pain relief with 30-60 minutes of daily consistent use for many users.
The device is FDA-registered and designed to support over 30 musculoskeletal conditions, including back pain, neck pain, knee pain, joint disorders, muscle stiffness, sports injuries, chronic injuries, and post-activity recovery.
“Building on the strong momentum of the last 12 months, we are now focused on scaling pan-India and establishing CURAPOD as the go-to solution for everyday pain management,” CURAPOD cofounder and CEO Velliyur said.
The startup said it is working on building a broader portfolio of light therapy-based solutions aimed at addressing multiple everyday health and recovery needs. It is targeting a 5X revenue growth in the next 12 months.
This comes at a time when healthtech funding and deal volumes have declined in India, even as the market is set to cross the $37 Bn mark by 2030. However, the healthtech 2.0 era is slowly developing, with the ecosystem shifting from episodic care to prevention.
Startups like Ultrahuman, Gabit, Noise, among others are selling devices and smart wearables to monitor physical health.
Eternal cofounder Deepinder Goyal is also exploring launching a wearable device company ‘Temple’, which would focus on selling wearable devices to monitor blood flow to the brain.
The post CURAPOD Bags ₹20 Cr To Scale Manufacturing Of Pain Management Device appeared first on Inc42 Media.